Saturday 7 November 2026 Export IAM’s income statement to Excel — free account

Iambic Therapeutics, Inc.

IAM Healthcare Biotechnology

Insider buying

10.20 1.44 −12.37%

Follow IAM

Alert me

Market cap: $551.7M
P/E: —
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview

Columns are period end dates